Situation: A 66-year-old man with small cell lung cancer is admitted with confusion, nausea, and muscle cramps. He has lost 9 kg over 3 months and eats poorly. His skin turgor and blood pressure are normal, and he has no edema. His results: serum sodium 116 mEq/L (135–145 mEq/L), serum potassium 3.1 mEq/L (3.5–5.0 mEq/L), serum osmolality 244 mOsm/kg (275–295 mOsm/kg), urine osmolality 540 mOsm/kg, and urine sodium 58 mEq/L. His thyroid and adrenal function are normal. Which explanation of his low serum sodium is correct?

He has low serum sodium and osmolality with inappropriately concentrated urine (540 mOsm/kg), high urine sodium, normal volume status, and normal thyroid and adrenal function: the picture of the syndrome of inappropriate antidiuretic hormone (SIADH), a common paraneoplastic effect of small cell lung cancer. Excess antidiuretic hormone makes the kidneys retain free water, which dilutes the serum sodium.

Core interpretation
This patient has euvolemic hypotonic hyponatremia caused by paraneoplastic SIADH from small cell lung cancer. The combination of low serum sodium (116 mEq/L), low serum osmolality (244 mOsm/kg), inappropriately concentrated urine (540 mOsm/kg), and high urine sodium (58 mEq/L) with normal volume status and normal thyroid/adrenal function is the classic diagnostic pattern of syndrome of inappropriate antidiuretic hormone secretion. Excess ADH makes the collecting ducts reabsorb free water even though the serum is already dilute, so the retained water expands total body water and dilutes serum sodium without causing edema.

Why the other options do not fit
Option 1 describes diuretic-like renal sodium loss causing volume depletion. However, this patient has normal skin turgor and blood pressure, no edema, and a urine sodium that is high but not because of a sodium-wasting state — the high urine sodium reflects ADH-driven water retention with ongoing dietary sodium intake, not true volume contraction. Option 2 suggests poor intake depleted total body sodium. Poor intake can contribute to hyponatremia, but it would typically produce a hypovolemic picture with low urine sodium as the kidneys conserve sodium. Here the urine sodium is high, which argues against simple depletion. Option 3 states water intake exceeded renal excretory capacity. That is partially true as a mechanism, but it does not explain why the kidneys cannot excrete the water. The defining problem is not the amount of water ingested; it is that ADH is preventing the kidneys from clearing free water.

Pathophysiology of SIADH in small cell lung cancer
Small cell lung cancer cells can ectopically produce ADH or ADH-like peptides. This paraneoplastic secretion is autonomous — it is not suppressed by low serum osmolality, which is the normal feedback signal. The result is sustained water retention in the collecting ducts through aquaporin-2 insertion. The retained water dilutes serum sodium, but because the water distributes across total body water, the patient remains euvolemic rather than edematous. Key point! Euvolemia plus concentrated urine plus high urine sodium is the triad that separates SIADH from hypovolemic or hypervolemic hyponatremia.

Diagnostic criteria applied to this case

Diagnostic feature	Expected in SIADH	This patient
Serum sodium	Low, hypotonic	116 mEq/L
Serum osmolality	Low	244 mOsm/kg
Urine osmolality	Inappropriately high, usually above 100 mOsm/kg	540 mOsm/kg
Urine sodium	Usually above 40 mEq/L with normal sodium intake	58 mEq/L
Volume status	Euvolemic	Normal turgor, normal BP, no edema
Thyroid and adrenal function	Normal	Normal

Why the urine is concentrated despite low serum osmolality
In a healthy person, a serum osmolality of 244 mOsm/kg would suppress ADH to near zero, and the urine would be maximally dilute, often below 100 mOsm/kg. Here the urine osmolality is 540 mOsm/kg, which means ADH activity is present when it should be absent. Watch out! The term “inappropriate” in SIADH refers specifically to this mismatch: ADH is acting despite hypotonic plasma. This is the single most important concept for recognizing SIADH on a licensure exam.

Clinical correlation with the patient’s symptoms
Confusion, nausea, and muscle cramps are neurologic and neuromuscular manifestations of acute or subacute hypotonic hyponatremia. As serum sodium falls, water shifts into brain cells, causing cerebral edema and neurologic dysfunction. The muscle cramps are also aggravated by the mild hypokalemia (3.1 mEq/L), which can accompany SIADH because increased distal tubular flow from water retention enhances potassium secretion. The weight loss and poor intake are consistent with advanced small cell lung cancer, but they are not the primary cause of the sodium abnormality. The paraneoplastic ADH secretion is the dominant driver of the hyponatremia, even in a patient who is eating poorly.

Why this matters for nursing care
SIADH-related hyponatremia in small cell lung cancer is common. One review notes hyponatremia occurs in approximately 25% of patients with small cell lung cancer, and SIADH accounts for about 60% of those cases ^[3]. Another review emphasizes that hyponatremia is the most common electrolyte complication of solid tumors, with an incidence up to 18.9% in small cell lung cancer, and that it negatively affects quality of life and prognosis ^[2]. For the bedside nurse, the priorities are strict intake and output monitoring, daily weights, neurologic checks, and safe correction of sodium. Fluid restriction is often the first-line intervention, and vasopressin receptor antagonists such as tolvaptan may be used in refractory cases ^[1]. Key point! Rapid overcorrection of chronic hyponatremia can cause osmotic demyelination syndrome, so sodium correction must follow protocol-based limits regardless of the underlying cause.